In this issue:
Rivaroxaban vs. warfarin for VTE and PTS risk
Thromboembolic event risk in AL amyloidosis
Postmarketing safety and efficacy of Advate® in haemophilia A
Automated RBC and platelet antigen typing
Haematological malignancy risk after radioiodine for well-differentiated thyroid cancer
HLA germline variation and transplant survivorship
Late mortality after autologous BMT in childhood
Prognostic model for high-tumourburden follicular lymphoma
Mutations that identify favourable response to chemotherapy in older de novo AML
Please login below to download this issue (PDF)